- News Home
24 April 2014 11:45 am ,
Vol. 344 ,
Major climate data sets have underestimated the rate of global warming in the last 15 years owing largely to poor data...
The tsetse fly is best known as the vector for the trypanosome parasites that cause sleeping sickness and a disease in...
The National Institutes of Health is revising its "two strikes" rule, which allowed researchers only one chance to...
By stabilizing the components of retromers, molecular complexes that act like recycling bins in cells, a recently...
Fossil fuels power modern society by generating heat, but much of that heat is wasted. Semiconductor devices called...
Researchers are gaining insights into what made Supertyphoon Haiyan so powerful and devastating through post-storm...
Millions around the world got a first-hand look at what it was like to be in Tacloban while it was pummeled by...
- 24 April 2014 11:45 am , Vol. 344 , #6182
- About Us
Hat in Hand, Specter Proposes New Agency to Race for the Cure
27 April 2009 1:46 am
Senator Arlen Specter (R-PA) says giving the U.S. National Institutes of Health billions more dollars isn't enough to bolster biomedical research. On Saturday at a clinical research meeting in Chicago, he proposed a new independent agency to move bench discoveries to the bedside. And he wants your money to help him keep his seat.
Specter led a push to give NIH $10.4 billion in the recent stimulus package. He's now drafted a bill to be introduced this week that would authorize NIH to receive that funding as part of its base budget, bringing the total to $40 billion.
He explains his plan at a Web site, specterforthecure.com, that also urges visitors to contribute to his election campaign—he's facing a difficult primary battle to hold onto his seat in 2010. The bill would also create what he calls the Cures Acceleration Network, an independent federal agency, funded at $2 billion a year, that would attempt to bridge the so-called valley of death between discovering a potential drug and testing it in patients.
The agency's aim would be to "turn discoveries in biomedical research into better health for the American people," said Specter, a two-time cancer survivor. Biotech companies, universities, and patient groups could all apply for the grants, Specter said.
At least one prominent scientist thinks the network is a great idea. Former National Human Genome Research Institute Director Francis Collins, who was at the same meeting, told ScienceInsider that Specter's proposal is a "bold step" and that "the medical community should ... line up and try to figure out how to make it happen."